Sage Therapeutics slumps as Biogen deal may dampen M&A hopes
April 20, 2018 at 15:45 PM EDT
Weakness in shares of Sage Therapeutics may be related to news that Biogen and Ionis Pharmaceuticals have expanded their strategic collaboration through a new ten-year collaboration agreement.